Atossa Therapeutics (YAG) Ownership - Who Owns Atossa Therapeutics?
Atossa Therapeutics (YAG) Ownership Overview
- 2.17% Insiders
- 27.61% Mutual Funds
- <0.01% Other Institutional Investors
- 3.89% ETFs
- 66.33% Public Companies and Individual Investors
The ownership structure of Atossa Therapeutics (DE:YAG) stock is a mix of institutional, retail, and individual investors. Approximately 31.50% of the company’s stock is owned by Institutional Investors, 2.17% is owned by Insiders, and 66.33% is owned by Public Companies and Individual Investors.
The ownership structure of Atossa Therapeutics (DE:YAG) stock is a mix of institutional, retail, and individual investors. Approximately 31.50% of the company’s stock is owned by Institutional Investors, 2.17% is owned by Insiders, and 66.33% is owned by Public Companies and Individual Investors.
Recent Insider Trading Activity
| Date | Name | Activity | Value |
|---|
Recent Hedge Fund Trading Activity
| Date | Firm | Activity | Value |
|---|---|---|---|
| Dec 31, 2025 | Graham Capital Management, L.p. | €124,708 |
Top Shareholders
| Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| Columbia Funds Series Trust I | 2,093,530 | Institution | 20.98% | 4,563,895 |
| Vanguard | 355,208 | Institution | 3.56% | 774,353 |
| Vanguard Index Funds | 355,208 | Institution | 3.56% | 774,353 |
| Kenneth Tropin | 211,369 | Institution | 2.12% | 460,784 |
| Columbia Funds Series Trust I | 201,434 | Institution | 2.02% | 439,126 |
| BlackRock, Inc. | 164,358 | Institution | 1.65% | 358,300 |
| Steven Quay | 89,521 | Insider | 0.90% | 195,156 |
| Fidelity Concord Street Trust | 76,660 | Institution | 0.77% | 167,119 |
| Daniel Mark James | 63,000 | Insider | 0.63% | 137,340 |
| Ishares | 32,537 | Institution | 0.33% | 70,931 |
Top Mutual Fund Holders
| Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| Columbia Funds Series Trust I | 2,093,530 | Institution | 20.98% | 4,563,895 |
| Vanguard Index Funds | 355,208 | Institution | 3.56% | 774,353 |
| Columbia Funds Series Trust I | 201,434 | Institution | 2.02% | 439,126 |
| Fidelity Concord Street Trust | 76,660 | Institution | 0.77% | 167,119 |
| Victory Portfolios Iii | 14,186 | Institution | 0.14% | 30,925 |
| Vanguard Valley Forge Funds | 6,539 | Institution | 0.07% | 14,255 |
| Morgan Stanley Pathway Funds | 6,272 | Institution | 0.06% | 13,673 |
| Profunds | 1,793 | Institution | 0.02% | 3,909 |
FAQ
Who Owns Atossa Therapeutics (DE:YAG)?
According to the latest TipRanks data, approximately 31.50% of the company's stock is held by institutional investors, 2.17% is held by insiders, and 66.33% is held by public companies and individual investors.
What percentage of Atossa Therapeutics (DE:YAG) stock is held by institutional investors?
According to the latest TipRanks data, approximately 31.50% of Atossa Therapeutics (DE:YAG) stock is held by institutional investors: 27.61% by mutual funds, 3.89% by ETFs and <0.01% by other institutional investors.
What percentage of Atossa Therapeutics (DE:YAG) stock is held by retail investors?
According to the latest TipRanks data, approximately 66.33% of Atossa Therapeutics (DE:YAG) stock is held by public companies and individual investors.
Who owns the most shares of Atossa Therapeutics (DE:YAG)?
Columbia Funds Series Trust I owns the most shares of Atossa Therapeutics (DE:YAG).
What is the significance of the ownership structure for a publicly traded company?
The ownership structure can impact the company's decision making, as large institutional investors may exert influence on the company's management and can also affect the company's stock price with their buying and selling patterns.
